Navigation Links
Memory Pharmaceuticals Completes Phase 1 Multiple Ascending Dose Study of R4996/MEM 63908
Date:9/26/2008

cals' prospects, future financial position, future revenues and projected costs should be considered forward-looking. Readers are cautioned that actual results may differ materially from projections or estimates due to a variety of important factors, including the outcome of clinical trials of Memory Pharmaceuticals' drug candidates and whether they demonstrate these candidates' safety and effectiveness; the risks and uncertainties associated with: obtaining additional financing to support Memory Pharmaceuticals' R&D and clinical activities and operations; obtaining regulatory approvals to conduct clinical trials and to commercialize Memory Pharmaceuticals' drug candidates; Memory Pharmaceuticals' ability to enter into and maintain collaborations with third parties for its drug development programs; Memory Pharmaceuticals' dependence on its collaborations and its license relationships; achieving milestones under Memory Pharmaceuticals' collaborations; Memory Pharmaceuticals' dependence on preclinical and clinical investigators, preclinical and clinical research organizations, manufacturers and consultants; protecting the intellectual property developed by or licensed to Memory Pharmaceuticals; and Memory Pharmaceuticals' ability to maintain listing on the Nasdaq Stock Market. These and other risks are described in greater detail in Memory Pharmaceuticals' filings with the Securities and Exchange Commission. Memory Pharmaceuticals may not actually achieve the goals or plans described in its forward-looking statements, and investors should not place undue reliance on these statements. Memory Pharmaceuticals disclaims any intent or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

http://www.memorypharma.com/index.html


'/>"/>
SOURCE Memory Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Gladstone scientists uncover potential mechanism of memory loss in Alzheimers disease
2. Scientists synthesize memory in yeast cells
3. Penn engineers design computer memory in nanoscale form that retrieves data 1,000 times faster
4. Penn engineers design computer memory in nanoscale form that retrieves data 1,000 times faster
5. Scientists synthesize memory in yeast cells
6. Amarin Announces Publication of Pre-Clinical Memory Data in Journal of Neurochemistry
7. BioMedical Enterprises, Inc. (BME) Receives FDA Clearance for Spine Use of Its Memory Metal Implants
8. ASU researchers improve memory devices using nanotech
9. Memory Pharmaceuticals to Announce Third Quarter Results on Thursday, November 8, 2007
10. Memory Pharmaceuticals Initiates Phase 2a Trial of MEM 3454 in Cognitive Impairment Associated with Schizophrenia
11. Amarin to Commence Phase II Trial With AMR101 in Age Associated Memory Impairment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... oxide ceramics have potential uses as ferroelectrics, fast ... nuclear waste, generating a great deal of scientific ... these blended materials. , "The interfaces separating the ... radiation properties of the material as a whole," ... researcher on the project. "It is in the ...
(Date:9/23/2014)... 2014 Erlab , the expert ... 1968 and Burdinola, supplier of laboratory furniture solutions, announce ... fume hood. , By integrating Erlab’s ... will now offer an innovative solution utilizing the patented ... chemicals, best-in-class detection technology, and communication for security and ...
(Date:9/23/2014)... CA (PRWEB) September 23, 2014 For the ... Inc. 500|5000 list of the fastest-growing companies. , ... been acknowledged yet again by Inc. Magazine,” ExakTime CEO Tony ... 5000 list by posting a three-year growth rate of 61 ... in that time by more than 40 percent. , Pappas ...
(Date:9/23/2014)... Sept. 23, 2014  Age Defying Dermatology ® , ... has become one of the first clinics in the ... aesthetic laser for tattoo removal. The treatment safely and ... "For years, tattoo removal has been a lengthy, painful, ... "This is an opportunity to erase tattoo pigment more ...
Breaking Biology Technology:Los Alamos researchers uncover properties in nanocomposite oxide ceramics for reactor fuel 2Erlab Partners with Burdinola to Deliver an Innovative Filtered Fume Hood 2ExakTime Makes Inc. 5000 List for the Fifth Time 2Age Defy Now Offers World's Most Advanced Technology for Tattoo Removal 2
... screening initiative launches in Atlanta and continues for 90 days;, ... in 13 cities ... across the country, ... specialty biopharmaceutical company, today,announced the launch of a 13-city mobile screening ...
... to Impact Lung Cancer Care, ST. LOUIS, ... start-up company, has secured $4.75M in venture capital ... delivery system for minimally,invasive biopsy and ablation of ... was joined by Advantage Capital Partners and existing ...
... EuroPCR08 will highlight choice of different modalities ... available on single integrated imaging platform., SAN DIEGO, ... VOLC ), a leading manufacturer and developer of,intravascular ultrasound ... designed to enhance the diagnosis and,treatment of coronary and ...
Cached Biology Technology:Shire Launches Nationwide Adult ADHD Mobile Awareness Tour 2Shire Launches Nationwide Adult ADHD Mobile Awareness Tour 3Shire Launches Nationwide Adult ADHD Mobile Awareness Tour 4Shire Launches Nationwide Adult ADHD Mobile Awareness Tour 5Veran Medical Technologies Secures $4.75M in First Institutional Funding 2Volcano Announces Placement of 1,000th s5 and s5i IVUS Imaging System 2Volcano Announces Placement of 1,000th s5 and s5i IVUS Imaging System 3Volcano Announces Placement of 1,000th s5 and s5i IVUS Imaging System 4
(Date:9/23/2014)... has domesticated animals, selecting the best traits possible ... an intriguing animal to examine adaptation to climate ... selected breeding and a wealth of livestock genome-wide ... study that combined molecular and environmental data, professor ... genes under environmental selection from domesticated sheep breeds. ...
(Date:9/23/2014)... at the University of Wisconsin-Madison and the Morgridge Institute ... to screen for neural toxins, helping flag chemicals that ... Health (NIH) announced today that the UW-Madison and Morgridge ... the promising work as part of the Tissue Chip ... $7 million over the three-year project. , The ...
(Date:9/23/2014)... new tissues during the healing process, cells must ... years, scientists believed this communication happened primarily through ... and the University of Pittsburgh have found that ... if not more crucial. The findings, published in ... the National Academy of Sciences , could lead ...
Breaking Biology News(10 mins):Being sheepish about climate adaptation 2UW-Madison team developing 'tissue chip' to screen neurological toxins 2UW-Madison team developing 'tissue chip' to screen neurological toxins 3The mechanics of tissue growth 2
... anything they want and never gain a pound, while others ... You may be seeing things correctly after all. According ... Genetics ( http://www.genetics.org ), this may have a biological ... with diet, rather than diet alone, are the main cause ...
... (CLOTS)an intensive five-day course offered by the Society ... interventional radiologists, neurointerventionalists, vascular neurologists and fellows-in-training with ... discuss all aspects of acute stroke management. ... in the United States, with about 600,000 new ...
... Just as cooking helps people digest food, pretreating polycarbonate ... of its bisphenol A (BPA) content may be ... eco-friendly way, scientists have found. Their new study is ... Mukesh Doble and Trishul Artham note that manufacturers produce ...
Cached Biology News:Why fad diets work well for some, but not others 2Explore stroke care with Society of Interventional Radiology's CLOTS 2
Mouse monoclonal antibody raised against a full length recombinant SNAPC5. NCBI Entrez Gene ID = SNAPC5...
Mouse monoclonal antibody raised against a partial recombinant CRKRS. NCBI Entrez Gene ID = CRKRS...
Mouse monoclonal antibody raised against a partial recombinant CRKRS. NCBI Entrez Gene ID = CRKRS...
Mouse monoclonal antibody raised against a partial recombinant PRKG1. NCBI Entrez Gene ID = PRKG1...
Biology Products: